Tag

Goldman Sachs

All articles tagged with #goldman sachs

Maia 200 Boost for MSFT Fails to Lift Stock Amid Xbox Shakeups
market-news1 day ago

Maia 200 Boost for MSFT Fails to Lift Stock Amid Xbox Shakeups

Goldman Sachs maintains a Buy on Microsoft after the Maia 200 AI inference accelerator is unveiled, praising AI compute advances and keeping a $600 target, even as MSFT shares slip about 2.5% in trading. The Maia 200’s parity with competitors helps MSFT’s AI compute margins narrative, while Xbox leadership shifts (Phil Spencer’s retirement; Asha Sharma’s ascent; Sarah Bond’s departure; Matt Booty’s promotion) signal internal reorganization. Analysts remain bullish with a Strong Buy consensus and an average target around $594, implying roughly 53% upside.

Goldman Sachs Finds AI Spending Had Little Impact on 2025 U.S. Growth
economy2 days ago

Goldman Sachs Finds AI Spending Had Little Impact on 2025 U.S. Growth

Goldman Sachs economists say AI-related investments in 2025 contributed essentially zero to U.S. GDP growth, arguing much of the spending is offset by imported hardware and measurement gaps, challenging the view of AI as a strong growth engine even as roughly $700B is projected to be spent on AI infrastructure this year; surveys also show many firms use AI but do not see productivity or employment gains.

Goldman: Trump immigration crackdown cuts immigrant employment by 80%, reshaping labor markets
business8 days ago

Goldman: Trump immigration crackdown cuts immigrant employment by 80%, reshaping labor markets

Goldman Sachs argues that the Trump administration’s immigration crackdown has driven an 80% drop in immigrant employment, materially altering the US labor market. The resulting tighter labor supply could hit sectors that rely on immigrant workers (e.g., agriculture, hospitality, construction), potentially lifting some native wages but weighing on productivity and overall GDP growth in the near term. The policy shift may have lasting demographic and economic effects if restrictive immigration persists.

Goldman Sachs launches AI-resilient software pair-trade, betting on AI winners
business11 days ago

Goldman Sachs launches AI-resilient software pair-trade, betting on AI winners

Goldman Sachs has introduced an AI-resilient software pair-trade that goes long on AI-adoption winners in cybersecurity and cloud (examples include Microsoft, Oracle, Accenture, Salesforce, Palo Alto Networks, CrowdStrike, DocuSign, Cloudflare) while shorting firms it views as vulnerable to AI-driven disruption, signaling a hedged stance on the AI transition within the software sector.

CTA Selling Could Spill Over: Goldman Sachs Flags $80B Equity Dump Threat to BTC, Gold & Silver
markets17 days ago

CTA Selling Could Spill Over: Goldman Sachs Flags $80B Equity Dump Threat to BTC, Gold & Silver

Goldman Sachs warns that systematic funds (CTAs) may unload up to $80 billion in U.S. equities in the coming weeks, potentially thinning liquidity and amplifying volatility. The cross-asset spillover could pressure Bitcoin, gold and silver as risk-off flows and liquidity conditions deteriorate, with CTAs already signaling selling in major indices and the possibility of further moves if key levels are breached.

Goldman highlights why high-beta momentum stocks went from winners to big losers
markets21 days ago

Goldman highlights why high-beta momentum stocks went from winners to big losers

Goldman Sachs says a basket of high-beta momentum stocks suffered its worst session since the COVID era, driven by the underperformance of past winners and a crowded, stretched momentum setup amid a tech rout. The move appears to be a broad unwind tied to elevated volatility and dispersion, not a single trigger, with Goldman warning that further downside is possible and recommending short-term hedging.

Wegovy Demand Spurs NVO Rally as Goldman Signals Near-Term Earnings Upside
business1 month ago

Wegovy Demand Spurs NVO Rally as Goldman Signals Near-Term Earnings Upside

Novo Nordisk’s shares rose about 3% after more than 18,000 Wegovy prescriptions were issued in the first week of the obesity-pill launch, as Goldman Sachs initiated a Buy rating and raised its price target from $54 to $68 on expected near‑term earnings gains. Wegovy was approved by the FDA in December and began selling in the U.S. via Amazon Pharmacy, offering a pill alternative to injections and potentially helping Novo Nordisk regain market share from Eli Lilly. On the street, analysts show a Moderate Buy consensus (9 analysts, mix of Buys/Holds/Sells), with an average target of about $57.40 implying roughly 10% downside from current levels.

Goldman Sachs Reclaims Wall Street Edge as Deals Boom in 2026
business1 month ago

Goldman Sachs Reclaims Wall Street Edge as Deals Boom in 2026

Goldman Sachs posted strong fourth-quarter earnings as dealmaking surged and its stock rose about 60% over the past year, signaling a return to Wall Street dominance. CEO David Solomon predicts 2026 could exceed 2021’s peaks in M&A and capital markets, backed by a big AI-driven overhaul (One Goldman Sachs 3.0) and a sizable tech budget. The firm sharpened its focus on its two core units—global banking/markets and asset & wealth management—while continuing to monetize Marcus as a deposits platform despite its consumer-banking missteps, growing assets under supervision to roughly $3.6 trillion and pursuing зов acquisitions and partnerships (Innovator ETF platform, Industry Ventures, and a T. Rowe Price deal) even as it ceded the Apple Card partnership to JPMorgan. Competition remains fierce from Citi and Wells Fargo as Goldman navigates the path forward with AI as an accelerator.

Goldman Sachs posts EPS beat, but Apple Card markdowns weigh on revenue
business1 month ago

Goldman Sachs posts EPS beat, but Apple Card markdowns weigh on revenue

Goldman Sachs posted Q4 2025 EPS of $14.01 (beat) and revenue of about $13.5B (miss vs. $13.9B). The shortfall came from Apple Card markdowns linked to the pending sale of the portfolio to JPMorgan, with Platform Solutions’ negative net revenue (-$1.68B) a drag. A reserve release for credit losses ($2.48B) partially offset the markdowns, and net interest income was strong, while Global Banking & Markets and Asset & Wealth Management showed solid results.